Sumitomo Mitsui Trust Group Inc. Has $31.58 Million Holdings in Avantor, Inc. (NYSE:AVTR)

Sumitomo Mitsui Trust Group Inc. decreased its holdings in Avantor, Inc. (NYSE:AVTR) by 1.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,498,903 shares of the company’s stock after selling 26,687 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.22% of Avantor worth $31,582,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Public Employees Retirement System of Ohio lifted its holdings in Avantor by 34.1% in the third quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock valued at $8,972,000 after buying an additional 88,205 shares during the period. Perpetual Ltd lifted its stake in shares of Avantor by 38.7% in the 4th quarter. Perpetual Ltd now owns 1,766,882 shares of the company’s stock valued at $37,228,000 after purchasing an additional 493,408 shares during the period. New York State Teachers Retirement System bought a new stake in shares of Avantor during the 3rd quarter valued at about $8,473,000. Everence Capital Management Inc. acquired a new stake in Avantor during the fourth quarter worth approximately $555,000. Finally, Teachers Retirement System of The State of Kentucky increased its holdings in Avantor by 45.8% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 723,178 shares of the company’s stock worth $18,708,000 after purchasing an additional 227,200 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of Avantor stock opened at $18.42 on Wednesday. Avantor, Inc. has a 12 month low of $18.19 and a 12 month high of $28.00. The firm has a market capitalization of $12.53 billion, a P/E ratio of 40.03, a P/E/G ratio of 3.87 and a beta of 1.28. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The business has a fifty day simple moving average of $21.68 and a two-hundred day simple moving average of $23.44.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter last year, the firm posted $0.22 earnings per share. On average, equities analysts forecast that Avantor, Inc. will post 0.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AVTR has been the topic of several research analyst reports. UBS Group reissued a “neutral” rating and set a $25.00 target price (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Wells Fargo & Company reduced their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Monday. Raymond James reaffirmed an “outperform” rating and set a $24.00 price target (down from $26.00) on shares of Avantor in a research note on Monday. Barclays reduced their price objective on Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Stifel Nicolaus lowered their target price on Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a research report on Monday. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $26.15.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.